Next Article in Journal / Special Issue
Evolution and Contribution of a Global Partnership against Measles and Rubella, 2001–2023
Previous Article in Journal
Determinants of Systemic SARS-CoV-2-Specific Antibody Responses to Infection and to Vaccination: A Secondary Analysis of Randomised Controlled Trial Data
Previous Article in Special Issue
Sustaining the Elimination of Measles, Rubella and Congenital Rubella Syndrome in the Americas, 2019–2023: From Challenges to Opportunities
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 12
Issue 6
10.3390/vaccines12060692
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Commentary

The Case for Assessing the Drivers of Measles Vaccine Uptake

by
Jessica Kaufman
1,2,*,
Ashleigh Rak
1,
Sophia Vasiliadis
1,
Navrit Brar
3,
Eeman Atif
3,
Jennifer White
4,5,
Margie Danchin
1,2,6 and
David N. Durrheim
4,5
1
Vaccine Uptake Group, Murdoch Children’s Research Institute, Melbourne, VIC 3052, Australia
2
Department of Paediatrics, The University of Melbourne, Melbourne, VIC 3052, Australia
3
Melbourne Medical School, The University of Melbourne, Melbourne, CIV 3052, Australia
4
Health Protection, Hunter New England Local Health District, Booth Building, Wallsend Health Services Longworth Avenue, Newcastle, NSW 2287, Australia
5
School of Medicine and Public Health, University of Newcastle, Newcastle, NSW 2308, Australia
6
Department of General Medicine, The Royal Children’s Hospital, Melbourne, VIC 3052, Australia
*
Author to whom correspondence should be addressed.
Vaccines 2024, 12(6), 692; https://doi.org/10.3390/vaccines12060692
Submission received: 30 April 2024 / Revised: 18 June 2024 / Accepted: 19 June 2024 / Published: 20 June 2024
(This article belongs to the Special Issue A World without Measles and Rubella: Meeting the Regional Elimination Targets on the Path to Global Eradication)
Versions Notes

Abstract

Global measles cases are on the rise following disruptions to routine immunisation programs during the COVID-19 pandemic, with devastating consequences. According to the World Health Organization, the behavioural and social drivers of vaccination include what people think and feel about vaccines, social processes, motivation to vaccinate and practical barriers to vaccination. However, the drivers of measles vaccine uptake are not necessarily the same as those for other childhood vaccines, and we lack data on how these drivers specifically have changed during and since the COVID-19 pandemic. Without accurately measuring the behavioural and social drivers for measles vaccination, and ideally measuring them serially over time, countries cannot design, target and implement interventions that effectively increase and sustain measles vaccine coverage. This paper outlines what is and is not known about the behavioural and social drivers of measles vaccination and provides recommendations for improving their post-pandemic assessment.
Keywords: vaccination; vaccine uptake; measles; MMR; social science; barriers; vaccine hesitancy vaccination; vaccine uptake; measles; MMR; social science; barriers; vaccine hesitancy

Share and Cite

MDPI and ACS Style

Kaufman, J.; Rak, A.; Vasiliadis, S.; Brar, N.; Atif, E.; White, J.; Danchin, M.; Durrheim, D.N. The Case for Assessing the Drivers of Measles Vaccine Uptake. Vaccines 2024, 12, 692. https://doi.org/10.3390/vaccines12060692

AMA Style

Kaufman J, Rak A, Vasiliadis S, Brar N, Atif E, White J, Danchin M, Durrheim DN. The Case for Assessing the Drivers of Measles Vaccine Uptake. Vaccines. 2024; 12(6):692. https://doi.org/10.3390/vaccines12060692

Chicago/Turabian Style

Kaufman, Jessica, Ashleigh Rak, Sophia Vasiliadis, Navrit Brar, Eeman Atif, Jennifer White, Margie Danchin, and David N. Durrheim. 2024. "The Case for Assessing the Drivers of Measles Vaccine Uptake" Vaccines 12, no. 6: 692. https://doi.org/10.3390/vaccines12060692

APA Style

Kaufman, J., Rak, A., Vasiliadis, S., Brar, N., Atif, E., White, J., Danchin, M., & Durrheim, D. N. (2024). The Case for Assessing the Drivers of Measles Vaccine Uptake. Vaccines, 12(6), 692. https://doi.org/10.3390/vaccines12060692

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop